Published December 2013 | Version v1
Journal article

Progress in diagnosis and treatment of radioactive iodine-refractory differentiated thyroid carcinomas

  • 1. Department of Oncology, the Affiliated Hospital of Qingdao University Medical College (China)

Description

During 131I therapy or the natural course of DTC, 2% to 5% of them will gradually no longer be sensitive to 131I therapy and lead to radioactive iodine-refractory DTC (RAIR-DTC). Recent studies found that alterations of critical molecular targets in main signal transduction pathways could decrease the iodine-trapping function of thyroid carcinoma, such as BRAFV600E mutation, followed by negative 131I-whole body scan (WBS) and discounted efficacy. This article reviews novel diagnostic and therapeutic modalities for RAIR-DTC. (authors)

Additional details

Publishing Information

Journal Title
Chinese Journal of Nuclear Medicine and Molecular Imaging
Journal Volume
33
Journal Issue
6
Journal Page Range
p. 505-509
ISSN
2095-2848

Optional Information

Notes
1 figs., 61 refs.